Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Meeting Planner — Week of May 8, 2023

  • Post author:PacConAdmin
  • Post published:May 10, 2023
  • Post category:Drug Industry Daily

Upcoming events in the coming weeks include six FDA advisory committee meetings as well as webinars and conferences on subjects ranging from medical device enforcement, real-world evidence and root cause…

Continue ReadingMeeting Planner — Week of May 8, 2023

MDIC Details Risk-Based CAPA Process in New White Paper Focused on Pilot

  • Post author:PacConAdmin
  • Post published:May 9, 2023
  • Post category:Drug Industry Daily

Device manufacturers that apply a more risk-based framework to corrective and preventive action (CAPA) plans rather than using the more typical one-size-fits-all approach could see reduction of up to 80…

Continue ReadingMDIC Details Risk-Based CAPA Process in New White Paper Focused on Pilot

FDA Final Guidance on Glycerin, High-Risk Drug Components Aims to Prevent Poisonings

  • Post author:PacConAdmin
  • Post published:May 9, 2023
  • Post category:Drug Industry Daily

The FDA has issued a final guidance to help manufacturers prevent the use of glycerin and other high-risk drug components contaminated with the toxic substances diethylene glycol (DEG) or ethylene…

Continue ReadingFDA Final Guidance on Glycerin, High-Risk Drug Components Aims to Prevent Poisonings

VHA, FDA and MHRA Team Up for AI/ML Cardiovascular Challenge

  • Post author:PacConAdmin
  • Post published:May 9, 2023
  • Post category:Drug Industry Daily

The Veteran’s Health Administration (VHA), working with the FDA and several other agencies, has launched a challenge for the scientific and data analytics communities to develop AI and machine learning…

Continue ReadingVHA, FDA and MHRA Team Up for AI/ML Cardiovascular Challenge

Interview: Director Kopcha Says Supply Chain, Quality Metrics Top OPQ’s Priority List

  • Post author:PacConAdmin
  • Post published:May 9, 2023
  • Post category:Drug Industry Daily

CDER’s Office of Pharmaceutical Quality (OPQ) Director Mike Kopcha leads an office of more than 1,300 staff involved in assessing drug marketing applications. FDAnews asked him about OPQ’s challenges, priorities…

Continue ReadingInterview: Director Kopcha Says Supply Chain, Quality Metrics Top OPQ’s Priority List

Legislative Update — Week of May 8, 2023

  • Post author:PacConAdmin
  • Post published:May 9, 2023
  • Post category:Drug Industry Daily

As the 118th Congress continues, FDAnews will be tracking the important pieces of pending legislation to keep you updated on regulations that could impact your business. Source: Drug Industry Daily

Continue ReadingLegislative Update — Week of May 8, 2023

Medtech Leaders Comment on EtO as a Device Sterilization Method at EPA Hearing

  • Post author:PacConAdmin
  • Post published:May 8, 2023
  • Post category:Drug Industry Daily

Use of ethylene oxide (EtO) for medical device sterilization is safe for employees, neighbors and communities, and is the only viable method for many of the 20 billion devices it…

Continue ReadingMedtech Leaders Comment on EtO as a Device Sterilization Method at EPA Hearing

U.S. Obesity Rate May Be the Undoing of Perrigo’s OTC Birth Control Pill

  • Post author:PacConAdmin
  • Post published:May 8, 2023
  • Post category:Drug Industry Daily

The rising obesity rate in the U.S. could foil Perrigo’s bid to offer the U.S.’s first OTC oral contraceptive, according to FDA briefing documents in advance of a two-day advisory…

Continue ReadingU.S. Obesity Rate May Be the Undoing of Perrigo’s OTC Birth Control Pill

MDSAP QMS Implementation Plan Highlights Ongoing Assessments and Improvements

  • Post author:PacConAdmin
  • Post published:May 8, 2023
  • Post category:Drug Industry Daily

A new document from the Medical Device Single-Audit Program (MDSAP) outlines the program’s plan for implementing its Quality Management System (QMS) guidance on how to design, strengthen and develop quality…

Continue ReadingMDSAP QMS Implementation Plan Highlights Ongoing Assessments and Improvements

EU Notified Bodies Can Use New Form Letter to Advise Devicemakers on Status

  • Post author:PacConAdmin
  • Post published:May 8, 2023
  • Post category:Drug Industry Daily

The nonprofit European Association of Medical Devices Notified Bodies, known as Team NB, has published a form letter for updating devicemakers on the status of their submissions as the EU…

Continue ReadingEU Notified Bodies Can Use New Form Letter to Advise Devicemakers on Status
  • Go to the previous page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 385
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.